Anaphase lag

Last updated

Anaphase lag is a consequence of an event during cell division where sister chromatids do not properly separate from each other because of improper spindle formation. [1] The chromosome or chromatid does not properly migrate during anaphase and the daughter cells will lose some genetic information. It is one of many causes of aneuploidy. This event can occur during both meiosis and mitosis with unique repercussions. In either case, anaphase lag will cause one daughter cell to receive a complete set of chromosomes while the other lacks one paired set of chromosomes, creating a form of monosomy. [2] Whether the cell survives depends on which sister chromatid was lost and the background genomic state of the cell. The passage of abnormal numbers of chromosomes will have unique consequences with regards to mosaicism and development as well as the progression and heterogeneity of cancers. [3]

Contents

Mechanisms

There are two notable mechanisms that cause Anaphase Lag, each of which are characterized by merotelic attachments of kinetochores to the microtubules responsible for chromatid separation. [4] Merotelic attachments occur when a single centromere kinetochore attaches to microtubules originating from both spindle poles of the dividing cell. The merotelic attachments can occur in two ways: centrosome spindle attachments from both poles on the same chromatid kinetochore [5] or the formation of a third centrosome whose microtubule spindles attach to a chromatid kinetochore. [6] Because the chromatid is being pulled in two opposing directions or away from the correct centriole, it cannot migrate to the mass of segregated chromatids at either pole. If the migration is significantly delayed the reformation of nuclei will begin to occur without a full complement of chromosomes. This nuclear envelope formation is also seen for the lone lagging sister chromatid, forming a micronucleus. The micronucleus has the capacity to persist in the daughter cell but with abnormal replication and maintenance machinery. This allows for the accumulation of mutations, increasing the potential for future miss-segregation events. [2] In total these events cause problematic aneuploid cells with increased genomic instability. This has important implications in the development and persistence of cancers as well as debilitating developmental diseases. [7]

Hallmark of cancer

One of the hallmarks of cancer formation and persistence is genomic instability, referring to the increased frequency in sequence mutation, chromosome rearrangement, and aneuploidy. [8] The instability allows a cancerous growth to increasingly diverge from normal cell growth and division, with the potential to gain new traits such as angiogenesis, immune system evasion, and loss of cell cycle checkpoint genes. Aneuploidy is a drastic divergence from the normal karyotype, as such the potential heterogeneity within these cells makes diagnosis and treatment increasingly difficult. [7]

Genomic causes

The increasing importance of genomic instability on cancer progression has been emphasized in recent years. [9] There are many ways to cause aneuploidy, however the genomic predispositions for these events are less well understood. In regards to the merotelic kinetochore attachments associated with anaphase lag, several genes have been implicated. Aurora B is a kinase active in late metaphase, and has been shown to function as a checkpoint for the proper attachments of centriole spindles to the chromatid kinetochores. When Aurora B was partially inhibited by a small molecule drug, Cimini et al. observed lagging chromatids at increasing frequency. [10] Similarly, mutations to the gene Stag2 have been associated with increased aneuploidy in cancers. Stag2 encodes a cohesin protein responsible for holding sister chromatids together pre-anaphase. Imaging of cells with Stag2 knock-outs showed increased frequency of lagging anaphase chromatids; subsequent gene correction in human glioblastoma cell lines reduced the occurrence of this genomic instability. [11]

Prognosis and treatment

Consequent of this genomic instability, the resulting cancer cells have the potential to diverge in sequence and gain new traits. This intratumoral heterogeneity creates a tumor mass with different genomic backgrounds as well as unique cellular traits and drug susceptibilities. [7] Several research groups have shown that heterogeneity and genomic instability are heavily correlated with poor patient outcomes and aggressive cancers. [12] Chang-Min Choi et al. examined the survival of individuals with adenocarcinoma of the lung. Those individuals with higher rates of chromosome instability were associated with worse 5-year survival curves. [13] This was similarly observed in a colorectal study by Walther et al. [14] These more aggressive heterogenous tumors also provide unique difficulties for treatment regimens. [15] To support this hypothesis, Duesberg et al. tested drug susceptibility on cell lines with and without aneuploidy. While the diploid cell lines remained drug sensitive, the aneuploid lines showed marked increases in mutation rates, drug resistance, and unintended morphological changes to cell phenotypes. [16] As the importance of genomic instability in cancer prognosis/treatment continues, identifying the causes and consequences of mechanisms such as anaphase lag will be critical to understanding how cancer develops as well as developing better multi-target therapies.[ citation needed ]

References

  1. "Human Molecular Genetics". Archived from the original on June 29, 2007.{{cite journal}}: Cite journal requires |journal= (help)
  2. 1 2 Holland, Andrew J; Cleveland, Don W (June 2012). "Losing balance: the origin and impact of aneuploidy in cancer". EMBO Reports. 13 (6): 501–514. doi:10.1038/embor.2012.55. ISSN   1469-221X. PMC   3367240 . PMID   22565320.
  3. Gordon, David J.; Resio, Benjamin; Pellman, David (March 2012). "Causes and consequences of aneuploidy in cancer". Nature Reviews Genetics. 13 (3): 189–203. doi:10.1038/nrg3123. ISSN   1471-0064. PMID   22269907. S2CID   4956346.
  4. Redli, Patrick M.; Gasic, Ivana; Meraldi, Patrick; Nigg, Erich A.; Santamaria, Anna (2016-10-10). "The Ska complex promotes Aurora B activity to ensure chromosome biorientation". The Journal of Cell Biology. 215 (1): 77–93. doi:10.1083/jcb.201603019. ISSN   0021-9525. PMC   5057281 . PMID   27697923.
  5. Cimini, Daniela; Fioravanti, Daniela; Salmon, E. D.; Degrassi, Francesca (2002-02-01). "Merotelic kinetochore orientation versus chromosome mono-orientation in the origin of lagging chromosomes in human primary cells" . Journal of Cell Science. 115 (3): 507–515. doi:10.1242/jcs.115.3.507. ISSN   0021-9533. PMID   11861758.
  6. Cosenza, Marco R.; Cazzola, Anna; Rossberg, Annik; Schieber, Nicole L.; Konotop, Gleb; Bausch, Elena; Slynko, Alla; Holland-Letz, Tim; Raab, Marc S.; Dubash, Taronish; Glimm, Hanno; Poppelreuther, Sven; Herold-Mende, Christel; Schwab, Yannick; Krämer, Alwin (2017-08-22). "Asymmetric Centriole Numbers at Spindle Poles Cause Chromosome Missegregation in Cancer". Cell Reports. 20 (8): 1906–1920. doi: 10.1016/j.celrep.2017.08.005 . ISSN   2211-1247. PMID   28834753.
  7. 1 2 3 Chen, Guangbo; Mulla, Wahid A.; Kucharavy, Andrei; Tsai, Hung-Ji; Rubinstein, Boris; Conkright, Juliana; McCroskey, Scott; Bradford, William D.; Weems, Lauren (2015-02-12). "Targeting the Adaptability of Heterogeneous Aneuploids". Cell. 160 (4): 771–784. doi:10.1016/j.cell.2015.01.026. ISSN   0092-8674. PMC   4328141 . PMID   25679766.
  8. Hanahan, Douglas; Weinberg, Robert A. (2011-03-04). "Hallmarks of Cancer: The Next Generation". Cell. 144 (5): 646–674. doi: 10.1016/j.cell.2011.02.013 . ISSN   0092-8674. PMID   21376230.
  9. Cimini, Daniela (2008-09-01). "Merotelic kinetochore orientation, aneuploidy, and cancer". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1786 (1): 32–40. doi:10.1016/j.bbcan.2008.05.003. ISSN   0304-419X. PMID   18549824.
  10. Cimini, Daniela; Wan, Xiaohu; Hirel, Christophe B.; Salmon, E.D. (2006-09-05). "Aurora Kinase Promotes Turnover of Kinetochore Microtubules to Reduce Chromosome Segregation Errors". Current Biology. 16 (17): 1711–1718. Bibcode:2006CBio...16.1711C. doi: 10.1016/j.cub.2006.07.022 . ISSN   0960-9822. PMID   16950108. S2CID   18117282.
  11. Solomon, David A.; Kim, Taeyeon; Diaz-Martinez, Laura A.; Fair, Joshlean; Elkahloun, Abdel G.; Harris, Brent T.; Toretsky, Jeffrey A.; Rosenberg, Steven A.; Shukla, Neerav (2011-08-19). "Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer". Science. 333 (6045): 1039–1043. Bibcode:2011Sci...333.1039S. doi:10.1126/science.1203619. ISSN   0036-8075. PMC   3374335 . PMID   21852505.
  12. McGranahan, Nicholas; Burrell, Rebecca A.; Endesfelder, David; Novelli, Marco R.; Swanton, Charles (2012-06-01). "Cancer chromosomal instability: therapeutic and diagnostic challenges". EMBO Reports. 13 (6): 528–538. doi:10.1038/embor.2012.61. ISSN   1469-3178. PMC   3367245 . PMID   22595889.
  13. Choi, Chang-Min; Seo, Kwang Won; Jang, Se Jin; Oh, Yeon-Mok; Shim, Tae-Sun; Kim, Woo Sung; Lee, Dong-Soon; Lee, Sang-Do (2009-04-01). "Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: Fluorescence in situ hybridization analysis of paraffin-embedded tissue from Korean patients". Lung Cancer. 64 (1): 66–70. doi:10.1016/j.lungcan.2008.07.016. ISSN   0169-5002. PMID   18814932.
  14. Walther, A.; Houlston, R.; Tomlinson, I. (2008-07-01). "Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis". Gut. 57 (7): 941–950. CiteSeerX   10.1.1.1019.9550 . doi:10.1136/gut.2007.135004. ISSN   0017-5749. PMID   18364437. S2CID   26360129.
  15. Lee, Alvin J X; Endesfelder, David; Rowan, Andrew J; Walther, Axel; Birkbak, Nicolai J; Futreal, P Andrew; Downward, Julian; Szallasi, Zoltan; Tomlinson, Ian P M (2011-03-01). "Chromosomal Instability Confers Intrinsic Multi-Drug Resistance". Cancer Research. 71 (5): 1858–1870. doi:10.1158/0008-5472.CAN-10-3604. ISSN   0008-5472. PMC   3059493 . PMID   21363922.
  16. Duesberg, P.; Stindl, R.; Hehlmann, R. (2000-12-19). "Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy". Proceedings of the National Academy of Sciences of the United States of America. 97 (26): 14295–14300. Bibcode:2000PNAS...9714295D. doi: 10.1073/pnas.97.26.14295 . ISSN   0027-8424. PMC   18912 . PMID   11121035.